Drug intelligence / Profile preview

paeoniflorin

Development stage
Phase 3
Modality
Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

Paeoniflorin is a monoterpenoid glycoside and the principal bioactive compound found in the roots of Paeonia species, such as Paeonia lactiflora and Paeonia suffruticosa. It has been used in traditional Chinese medicine for over 2,000 years. Pharmacologically, paeoniflorin exhibits a broad spectrum of activities including anti-inflammatory, antioxidant, immunomodulatory, hepatoprotective, neuroprotective, antiplatelet, hypoglycemic (antidiabetic), antifibrotic, and cardiovascular protective effects[3][5][10]. Its mechanisms involve modulation of multiple signaling pathways such as TLR4-NF-κB (anti-inflammatory), PI3K/Akt/Nrf2 (antioxidant), JAK2/STAT6 (fibrosis inhibition), regulation of glucose metabolism via enhanced insulin sensitivity and secretion[3], inhibition of hepatic stellate cell activation[5], and protection against ischemia-reperfusion injury in neural tissue[7]. Preclinical studies suggest low toxicity with favorable safety profiles. It is under investigation for diabetes management and liver diseases.

Other names
peoniflorinpaeoniflormpaeony root (as source)Delmacinone
02

Targets

TLR4 (Toll-like receptor 4)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on paeoniflorin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on paeoniflorin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call